A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer
Corina E. Antal(Salk Institute for Biological Studies), Ronald M. Evans(University of California San Diego), Hervé Tiriac(University of California San Diego), Morgan Truitt(University of California, San Francisco), Senada Bashi(Salk Institute for Biological Studies), Jolene K. Diedrich(Scripps Research Institute), Nicole M. Sodir(University of Cambridge), Haiyong Han(Translational Genomics Research Institute), Cory Fraser(Scottsdale Community College), David Propper(St Bartholomew's Hospital), Gérard I. Evan(King's College - North Carolina), Henry Jiao(University of California San Diego), Brian A. Yee(University of California San Diego), Jasmine R. Mueller(University of California San Diego), Christopher Liddle(The University of Sydney), Gabriela Estepa(Salk Institute for Biological Studies), Allen Wang(University of California San Diego), Jan Lumibao(University of Illinois Urbana-Champaign), Ruth T. Yu(Peking University), Edgar Esparza(University of California San Diego), Elizabeth Lenkiewicz(Mayo Clinic in Arizona), Nasun Hah(Salk Institute for Biological Studies), Ester Banayo(Salk Institute for Biological Studies), Annette R. Atkins(Salk Institute for Biological Studies), Dannielle D. Engle(Cold Spring Harbor Laboratory), Erkut Borazanci(HonorHealth), En‐Ching Luo(University of California San Diego), Stefan Aigner(University of California San Diego), Michael T. Barrett(Mayo Clinic in Arizona), Daniel D. Von Hoff(Translational Genomics Research Institute), G Yeo(Institut de Biologie Moléculaire et Cellulaire), Michael Downes(Salk Institute for Biological Studies), Andrew M. Lowy(UC San Diego Health System), Cheng Zhang(University of California San Diego), Rubén M. Muñoz(Translational Genomics Research Institute), Katherine Rothamel(University of California San Diego), Tania Campos(The Francis Crick Institute), Tae Gyu Oh(University of Oklahoma Health Sciences Center)
Cited by 37
Related Papers
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
|New England Journal of Medicine|2013|6.6k
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.
|Journal of Clinical Oncology|1997|5.9k
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
|Cell|2014|2.2k
SXR, a novel steroid and xenobioticsensing nuclear receptor
|Genes & Development|1998|918